PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: Frost & Sullivan

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Demetech Picks Up Frost & Sullivan Technology Innovation Award for its Proprietary DXL Technology - The 2007 Frost & Sullivan Technology Innovation Award in the European bone densitometry systems market is conferred upon Demetech for its proprietary Dual X-Ray and Laser (DXL) technology
Demetech Picks Up Frost & Sullivan Technology Innovation Award for its Proprietary DXL Technology

 

NewswireToday - /newswire/ - London, United Kingdom, 2007/02/07 - The 2007 Frost & Sullivan Technology Innovation Award in the European bone densitometry systems market is conferred upon Demetech for its proprietary Dual X-Ray and Laser (DXL) technology.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Medical Services/Equipment Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

This innovative system is set to fulfill the need for a technology that accurately determines bone density in a cost-effective manner.

Demetech is the only company in the market with DXL technology and has patented it in Europe, North America, China and Japan. Among the technology's key benefits are high precision and accuracy, rapid scanning, user friendliness and affordability.

"Due to the method used by the current standard, Dual Energy X-Ray Absorptiometry (DEXA) technology, persons with very low or high fat content get distorted results, with fat error estimated to be anywhere between 10 and 40 per cent for individual patients," notes Frost & Sullivan Research Analyst Divya B. "Demetech's DXL Calscan solves this issue by innovatively combining a dual-wavelength X-ray source with laser definition of the measurement area."

Demetech's DXL Calscan technology measures bone density in the heel, which consists of 95 per cent trabecular bone. The system measures thickness, and determines how far the photons have had to travel through fat, bone and water before they are either absorbed or not absorbed. DEXA is unable to provide this additional information. Accordingly, DXL provides a more accurate estimate of the amount of fat and therefore, a more accurate measurement of bone density.

For 2007, Demetech's R&D expenditure as a percentage of cost is estimated to be between 15 and 20 per cent. As part of its ongoing R&D initiatives, Demetech is currently conducting a new breakthrough study involving over 15,000 patient examinations, in collaboration with Stockholm-based Karolinska Institute. The study is expected to prove that Calscan can predict hip fractures as efficiently as, if not better than, axial DEXA machines, based upon cross-sectional fracture results from the same population.

"In a market characterised by the established DEXA technology, Demetech has carved a niche for itself by investing substantially in R&D activities," observes Ms. Divya. "Through a well-established distribution network and focused marketing strategies, the company is poised to fulfill the need for affordable yet accurate technology alternatives in the European bone densitometry market."

Demetech is already demonstrating this in eastern European countries such as Turkey and Serbia where it claims to be the largest selling densitometry systems company. It is also planning on launching Calscan DXL in North America in the near future and has already made inroads into South America and the Middle East.

"Demetech is set to achieve success, having developed an alternative technology that offers accuracy in detection of bone density in a cost-effective manner," concludes Ms. Divya. "By enabling the early diagnosis and treatment of osteoporosis in a primary care setting, patient quality of life may be extended using DXL Calscan."

The Frost & Sullivan Award for Technology Innovation is presented to the company that has demonstrated technological superiority within its industry. This Award recognises the ability of the company to successfully develop and introduce new technology, formulate a well-designed product family, and make significant product performance contributions to the industry.

Frost & Sullivan Best Practices Awards recognise companies in a variety of regional and global markets for demonstrating outstanding achievement and superior performance in areas such as leadership, technological innovation, customer service, and strategic product development. Industry analysts compare market participants and measure performance through in-depth interviews, analysis, and extensive secondary research in order to identify best practices in the industry.

About Demetech AB

In late 2005, Scanflex International AB, a leading provider of state-of-the-art imaging systems for orthopedic surgery and products for personal radiation protection, acquired Demetech. This acquisition strengthens Demetech's position in the market. Demetech develops, manufactures and markets systems for the diagnosis and early detection of osteoporosis. Demetech, headquartered in Sweden, was founded in 1996 through funding by Venture Capitalists. Dual X-ray and Laser, commonly called DXL, was invented by a team of Swedish doctors, researchers and engineers. Demetech's DXL Calscan machine is the first instrument based on this technology. The clinical trials for Demetech's DXL Calscan system, which began in 1997 ended in 2000. Demetech's first DXL Calscan system was sold in Sweden in 2001 and since then they have sold 100 units in Sweden. In the year 2004, Demetech obtained the U.S. Food and Drug Administration clearance for Calscan.

About Frost & Sullivan

Frost & Sullivan, a global growth consulting company, has been partnering with clients to support the development of innovative strategies for more than 40 years. The company's industry expertise integrates growth consulting, growth partnership services and corporate management training to identify and develop opportunities. Frost & Sullivan serves an extensive clientele that includes Global 1000 companies, emerging companies, and the investment community, by providing comprehensive industry coverage that reflects a unique global perspective and combines ongoing analysis of markets, technologies, econometrics, and demographics.

For further information, please contact:
John Elliott, Dir. of Marketing & Sales, Demetech AB, Taby, Sweden
T: +46-733-105099, info[.]demetech.com

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Medical Services/Equipment Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: Frost & Sullivan

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+] / [Company listed above is a registered member of our network. Content made possible by PRZOOM / PRTODAY indexing services]

 
 
# # #
 
 
  Your Banner Ad showing on ALL
Medical Services/Equipment articles,
CATCH Visitors via Your Competitors Announcements!


Demetech Picks Up Frost & Sullivan Technology Innovation Award for its Proprietary DXL Technology

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

|
Publisher Contact: Sandra Holze - Promotions Co-ordinator, 
+44-(0)20-7915-7866 sandra.holze[.]frost.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Frost & Sullivan securities in any jurisdiction including any other companies listed or named in this release.

Medical Services/Equipment via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Frost & Sullivan / Company Profile


Read Medical Services/Equipment Most Recent Related Newswires:

ZOLL Canada Wins Tender to Equip Province of Québec Paramedic Services with ZOLL X Series Monitor/Defibrillators
Top Speakers, Brands Commit to SCBIO 2017 - SC Governor McMaster to Keynote Life Sciences Conference
Frost & Sullivan Recognizes Acelity as a Leader in the Field with its New V.A.C.ULTA™ 4 Therapy System and V.A.C. VERAFLO CLEANSE CHOICE™ Dressing
Frost & Sullivan Recognizes Ventec Life Systems for New Product Innovation - Game-changing, Modular Respiratory System, VOCSN
BD Expands Genomics Portfolio with New Single Cell Platform for RNA Expression Analysis
GE Healthcare Advances the Delivery of Cell Therapies with New Thawing Technology
Ansell Limited Announces the Closing of the Sale of its Sexual Wellness Business
PQ Bypass Earns Frost & Sullivan’s European Technology Innovation Award for its Proprietary DETOUR System for Percutaneous Bypass
Curaçao EMS Uses ZOLL Autopulse to Save Tourist in Sudden Cardiac Arrest
ZOLL to Showcase Expanded Portfolio of AEDs at Caravan Salon 2017
MDxHealth Announces Service Agreement with Kaiser Southern California Permanente Medical Group
Frost & Sullivan Lauds CytoSorbents for Leading the Critical Care Immunotherapy Segment with its Novel Blood Purification Solution, CytoSorb®
MVZ Dr. Stein & Kollegen First German Medical Laboratory to Offer the SelectMDx for Prostate Cancer Test
Datalogic Announces New Healthcare Memor X3 HC Mobile Computer
Neuronix Ltd Announces the First Group of Mild to Moderate Alzheimer Patients to be Successfully Treated by The NeuroAD™ Therapy System

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  La Bella Bakery Artisan Bakery Arizona

Visit  SKS Media | SKS Associates Ltd





 
  ©2017 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)